J&J Studying Probiotic Strain For Infant Dermatitis
Executive Summary
J&J Consumer in partnership with Infinant Health is conducting a prospective clinical trial to assess the immunological effect of supplementation with probiotic strain bifidobacterium infantis EVC001 in healthy breastfed infants at risk of developing atopic dermatitis.